Exact claim · Version 1 · Reviewed 2026-07-23
“Compounded PT-141 has the same evidence as Vyleesi.”
A verdict on this wording and scope, not a universal grade for Bremelanotide.
01 · Verdict
Not established
The trial and approval record are product-specific and do not establish equivalence for compounded material.
- Evidence basis
- Regulatory or product record
- Scope
- Compounded or research-labeled bremelanotide products.
- Category
- Product equivalence
02 · Primary record
Check the attached evidence
- Editorial review
- Internal editorial review recorded
- Responsible editor
- Anthony Treviso · Founder and responsible editor
- Clinical-review boundary
- Not independently medically reviewed.